ProfileGDS4718 / 221071_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 70% 58% 62% 68% 60% 62% 59% 65% 63% 68% 63% 54% 57% 59% 61% 58% 57% 55% 68% 57% 57% 60% 66% 63% 54% 61% 64% 73% 60% 49% 58% 58% 64% 58% 55% 59% 59% 59% 49% 62% 57% 56% 60% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7637269
GSM549102patient 115, normal, homogenized [OPG study]6.8348870
GSM549104patient 119, normal, homogenized [OPG study]5.9983258
GSM549108patient 138, normal, homogenized [OPG study]6.3052362
GSM549119patient 077, normal, homogenized [OPG study]6.6860268
GSM549133patient 032, cancer, homogenized [OPG study]6.0864860
GSM549139patient 042, cancer, homogenized [OPG study]6.2744462
GSM549099patient 107, normal, homogenized [OPG study]6.0477859
GSM549109patient 139, normal, homogenized [OPG study]6.4913265
GSM549110patient 046, normal, homogenized [OPG study]6.3317563
GSM549114patient 063, normal, homogenized [OPG study]6.6585268
GSM549122patient 082, normal, homogenized [OPG study]6.3793563
GSM549134patient 033, cancer, homogenized [OPG study]5.7528554
GSM549136patient 036, cancer, homogenized [OPG study]5.9207957
GSM549140patient 044, cancer, homogenized [OPG study]6.0303359
GSM549111patient 047, normal, homogenized [OPG study]6.2046761
GSM549113patient 057, normal, homogenized [OPG study]5.9745458
GSM549132patient 031, cancer, homogenized [OPG study]5.9536157
GSM549137patient 038, cancer, homogenized [OPG study]5.7721955
GSM549142patient 047, cancer, homogenized [OPG study]6.6906468
GSM549100patient 110, normal, homogenized [OPG study]5.9458857
GSM549107patient 135, normal, homogenized [OPG study]5.9147557
GSM549115patient 068, normal, homogenized [OPG study]6.1128660
GSM549116patient 072, normal, homogenized [OPG study]6.5397966
GSM549120patient 078, normal, homogenized [OPG study]6.319763
GSM549131patient 030, cancer, homogenized [OPG study]5.7270654
GSM549118patient 074, normal, homogenized [OPG study]6.1778661
GSM549129patient 027, cancer, homogenized [OPG study]6.4488464
GSM549123patient 088, normal, homogenized [OPG study]7.1447373
GSM549124patient 006, cancer, homogenized [OPG study]6.113860
GSM549126patient 015, cancer, homogenized [OPG study]5.4490449
GSM549128patient 025, cancer, homogenized [OPG study]6.0142558
GSM549103patient 117, normal, homogenized [OPG study]6.0354658
GSM549117patient 073, normal, homogenized [OPG study]6.3182164
GSM549138patient 041, cancer, homogenized [OPG study]6.0114958
GSM549141patient 045, cancer, homogenized [OPG study]5.8063155
GSM549130patient 028, cancer, homogenized [OPG study]6.0708659
GSM549101patient 111, normal, homogenized [OPG study]6.1161659
GSM549105patient 128, normal, homogenized [OPG study]6.0900959
GSM549106patient 134, normal, homogenized [OPG study]5.4225849
GSM549112patient 048, normal, homogenized [OPG study]6.2687262
GSM549125patient 011, cancer, homogenized [OPG study]5.9551457
GSM549127patient 024, cancer, homogenized [OPG study]5.8933756
GSM549135patient 035, cancer, homogenized [OPG study]6.1409460